SEC Form 4 · accession 0001235802-16-000251
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua J Baltzell
Director
Period of report
Jun 14, 2016
Accepted (ET)
Jun 15, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | holding | — | — | — | 1,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.26 | Jun 14, 2016 | A | 10,000 | A | — | Jun 14, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option vests in full on the earlier to occur of June 14, 2017 and the date of the Company's annual meeting of stockholders following June 14, 2016, subject to the Reporting Person's continued service with the Company through the applicable vesting date.